Farzan Nima (CIK 1808296) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-08). Recent activity: Sell KROS (2,625 shares), Buy KROS (7,142 shares), Buy KROS (5,250 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | Keros Therapeutics, Inc. (KROS) | Director | Sell | 2,625 | $28,166 |
| 2026-06-05 | Keros Therapeutics, Inc. (KROS) | Director | Buy | 7,142 | $0 |
| 2025-06-06 | Keros Therapeutics, Inc. (KROS) | Director | Buy | 5,250 | $0 |
Source: SEC Form 4 filings · as of 2026-06-08